Growing peptide focus CEM Corporation has recent and ongoing product launches in peptide purification and synthesis, including Prodigy 2.0 and the Peptide Purification system, signaling a strong market emphasis on peptide workflows which presents opportunities to upsell or bundle connected purification and synthesis solutions.

Global expansion With subsidiaries across Europe and Asia (UK, France, Germany, Ireland, Italy, Japan, India) and a global customer base, there is potential to expand account coverage, cross-sell products, and leverage regional partnerships to win multi-location contracts in analytical chemistry, biotech, and environmental testing.

Microwave synthesis leadership CEM’s core strength in microwave-based solutions with a long patent portfolio and multiple R&D awards highlights a defensible technology moat. Sales opportunities exist to target customers seeking faster synthesis cycles, scale-up capabilities, and improved yield with microwave platform integrations.

Large-scale capabilities Liberty PRO and other large-scale automated systems indicate capacity for high-throughput production. This aligns with prospects in biopharma, peptide manufacturing, and environmental testing that require scalable synthesis and purification solutions.

Cross-industry applicability Active presence in analytical lab, chemical synthesis, biotechnology, environmental testing, and food processing markets suggests cross-selling potential across multiple departments within target accounts, including R&D, manufacturing, quality control, and procurement.